Hewatele key facts
- Supplier of medical oxygen intended to reduce the delay in access to emergency healthcare in remote parts of Africa.
- It has raised $43.5M; the latest was Later Stage VC ($10.5M) in Aug 2025.
- Notable investors include Africinvest, Finnish Fund for Industrial Cooperation, Grand Challenges Canada, Soros Economic Development Fund, Open Society Foundations — 8 tracked in total.
- Status: Privately Held (backing).
- ·Watch Hewatele: the Monday email on marks, rounds and moves
Hewatele funding rounds
No funding rounds for Hewatele are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Hewatele investors
8 investors are on record for Hewatele, including Africinvest, Finnish Fund for Industrial Cooperation, Grand Challenges Canada and Soros Economic Development Fund.
About Hewatele
Supplier of medical oxygen intended to reduce the delay in access to emergency healthcare in remote parts of Africa. The company's services include supplying elements needed in surgical situations, enabling public hospitals, private not-for-profit hospitals, and needy patients to meet their needs at an affordable price.
- Sector
- Healthcare
- HQ
- Nairobi, Kenya
- Founded
- 2014
- Employees
- 20
- Website
- hewatele.org/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
Hewatele doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.